» Articles » PMID: 30170791

LncRNAs Expression Profile in Peripheral Blood Mononuclear Cells from Multiple Sclerosis Patients

Abstract

LncRNA PCR arrays containing 90 common LncRNAs were used to screen lncRNA expression levels in PBMC from a discovery population of patients with MS. Data from discovery and replications cohorts showed a generalized dysregulation of lncRNA levels in MS patients compared with controls. MALAT1, MEG9, NRON, ANRIL, TUG1, XIST, SOX2OT, GOMAFU, HULC, BACE-1AS were significantly downregulated in MS patients in comparison with controls. Therefore, we performed a validation analysis in an independent cohort of Belgian origin. In this study, NRON and TUG1 downregulations in MS patients compared with controls were confirmed (p ≤ .05 and p ≤ .0001 respectively), whereas considering the other lncRNAs, the statistical threshold was not reached. LncRNAs profiling could thus represent a new challenge in the research of easy detectable biomarkers of disease susceptibility and progression.

Citing Articles

Biological functions and affected signaling pathways by Long Non-Coding RNAs in the immune system.

Ghahramani Almanghadim H, Karimi B, Valizadeh S, Ghaedi K Noncoding RNA Res. 2024; 10:70-90.

PMID: 39315339 PMC: 11417496. DOI: 10.1016/j.ncrna.2024.09.001.


Exosomal Non-coding RNA Derived from Mesenchymal Stem Cells (MSCs) in Autoimmune Diseases Progression and Therapy; an Updated Review.

Farhan S, Jasim S, Bansal P, Kaur H, Abed Jawad M, Qasim M Cell Biochem Biophys. 2024; 82(4):3091-3108.

PMID: 39225902 DOI: 10.1007/s12013-024-01432-4.


lncRNA Biomarkers of Glioblastoma Multiforme.

Pokorna M, Cerna M, Boussios S, Ovsepian S, OLeary V Biomedicines. 2024; 12(5).

PMID: 38790894 PMC: 11117901. DOI: 10.3390/biomedicines12050932.


LncRNA: A multifunctional key player in non-oncological pathological conditions.

Zeinelabdeen Y, Abaza T, Yasser M, Elemam N, Youness R Noncoding RNA Res. 2024; 9(2):447-462.

PMID: 38511054 PMC: 10950597. DOI: 10.1016/j.ncrna.2024.01.011.


Exosome Content-Mediated Signaling Pathways in Multiple Sclerosis.

Mohammadinasr M, Montazersaheb S, Ayromlou H, Hosseini V, Molavi O, Hejazi M Mol Neurobiol. 2024; 61(8):5404-5417.

PMID: 38191693 DOI: 10.1007/s12035-023-03862-2.